The usefulness of whole genome sequencing in diagnosis and clinical management of drug-resistant tuberculosis patients in Tanzania
Not Applicable
- Conditions
- Application of whole genome sequencing in multidrug resistance tuberculosis patientsInfections and Infestations
- Registration Number
- ISRCTN14635089
- Lead Sponsor
- Tanzania Commission for Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 153
Inclusion Criteria
1. TB patients aged =18 years
2. Confirmed either as MDR-TB or non MDRTB using DST, Xpert® MTB/RIF assay GeneXpert® (Cepheid, Sunnyvale, CA, USA), GenoType MTBDRplus (Hain Life science, GmbH, Nehren)
3. Willingness to sign a written informed consent and provide sputum samples for laboratory analysis.
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method